Should we do cardiac stress tests in asymptomatic renal transplant candidates?

Area of Science:

• Nephrology
• Cardiology
• Transplantation Medicine

Background:

• Controversy exists regarding optimal cardiac evaluation for asymptomatic renal transplant candidates.
• Current guidelines (KDOQI, AST, Lisbon) show low positive predictive value for ischemia on noninvasive stress tests (5-10%).
• This study compares echocardiography and stress testing for predicting cardiac events in this population.

Purpose of the Study:

• To compare the predictive ability of simple transthoracic echocardiography versus noninvasive stress testing for cardiac events.
• To evaluate cardiac outcomes within 3 years post-transplantation in asymptomatic renal transplant candidates.
• To assess the utility of echocardiography as a primary cardiac evaluation tool.

Main Methods:

• Asymptomatic patients with good functional capacity, recommended for cardiac stress testing by KDOQI/AST guidelines and without prior cardiovascular disease, were selected.
• Group A (n=124) underwent echocardiography only; Group B (n=41) underwent echocardiography and noninvasive stress testing.
• Incidences of cardiac events and cardiac death were tracked for 3 years post-transplantation.

Main Results:

• No significant difference in ischemic heart disease incidence between groups (4% vs. 4.8%, P=.88).
• Only 4 patients in Group B had positive stress tests, with no obstructive coronary disease found.
• No cardiac deaths occurred in either group within the 3-year follow-up period.

Conclusions:

• Simple echocardiography demonstrated similar predictive ability for ischemic heart disease as stress testing in selected asymptomatic renal transplant candidates.
• Echocardiography may be a suitable alternative for cardiac evaluation in patients with good functional capacity, younger age, lower diabetes prevalence, and shorter dialysis duration.
• Findings suggest echocardiography can effectively identify candidates at low risk for cardiac events.